Physician profile
John T Moor
NPI 1225065410
$81,503.50
in general payments reported to CMS, 2019-2025
42 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,507 · 2021: $754 · 2022: $15K · 2023: $50K · 2024: $619 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $43K · Food and Beverage: $7,255 · Education: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $43,200.00 |
| Food and Beverage | $7,254.68 |
| Education | $297.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $49,127.29 | 2019-2023 | |
| Lima USA, INC. | $14,703.45 | 2022 | |
| Medacta USA, INC. | $10,270.48 | 2019 | |
| Stryker Corporation | $1,703.52 | 2019-2025 | Triathlon, Actishield, T2 Alpha |
| Encore Medical, LP | $1,532.60 | 2019 | |
| Arthrex, INC. | $1,119.26 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $316.01 | 2019-2025 | Exparel |
| Radius Health, INC. | $298.48 | 2019-2024 | Tymlos |
| Zimmer Biomet Holdings, INC. | $278.58 | 2022 | |
| Ferring Pharmaceuticals INC. | $227.43 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $215.54 | 2019-2024 | Xiaflex |
| Depuy Synthes Sales INC. | $198.88 | 2019-2025 | Orthovisc, Dynacord, Healix Knotless Peek |
| Wright Medical Technology, INC. | $140.34 | 2019 | |
| Smith+Nephew, INC. | $122.92 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Horizon Therapeutics Plc | $115.53 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fx Shoulder Solutions, INC | $89.65 | 2019 | |
| Microport Orthopedics INC | $87.20 | 2020 | |
| Amgen INC. | $77.71 | 2022-2025 | Evenity, Prolia |
| Exactech, INC. | $75.22 | 2021 | |
| Innovation Technologies INC | $67.54 | 2022-2025 | Irrisept |
| Total Joint Orthopedics, INC. | $66.71 | 2023 | |
| Mvp Orthopedics INC | $59.13 | 2021-2022 | |
| Baxter Healthcare | $55.78 | 2024 | Floseal, Tisseel |
| Si-Bone, INC. | $55.05 | 2023 | |
| Orthofix Medical, INC. | $54.02 | 2021 | |
| Vericel Corporation | $40.90 | 2019 | |
| Endo USA, INC. | $38.64 | 2024-2025 | Xiaflex |
| Ethicon US, LLC | $38.08 | 2022 | |
| Fidia Pharma USA INC. | $34.96 | 2019-2020 | |
| Heraeus Medical, LLC. | $34.03 | 2021 | |
| Bioventus LLC | $30.40 | 2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Biocomposites INC | $26.07 | 2019-2020 | |
| Onkos Surgical, INC. | $25.04 | 2020 | |
| Djo, LLC | $24.37 | 2024 | Cmf |
| Linvatec Corporation | $24.08 | 2019 | |
| Pacira Therapeutics, INC. | $23.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.78 | 2023 | Seglentis |
| Forte Bio-Pharma LLC | $20.00 | 2019 | |
| Kci USA, INC. | $18.90 | 2021 | |
| Sonex Health, INC. | $17.63 | 2020 | |
| Trice Medical, INC. | $15.24 | 2022 | |
| Zyla Life Sciences, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.